ARTICLE | Company News
BioStratum in formulation deal with Shire
November 29, 2000 8:00 AM UTC
Shire Laboratories, a subsidiary of Shire Pharmaceuticals (LSE:SHP; SHPGY), will use its drug delivery technologies to develop an extended release formulation of Pyridorin, an advanced glycation end p...